These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7336421)

  • 21. Imlifidase Inhibits HLA Antibody-mediated NK Cell Activation and Antibody-dependent Cell-mediated Cytotoxicity (ADCC) In Vitro.
    Ge S; Chu M; Choi J; Louie S; Vo A; Jordan SC; Toyoda M
    Transplantation; 2020 Aug; 104(8):1574-1579. PubMed ID: 32732834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of stimulation in murine mixed lymphocyte cultures with an alloantiserum directed against a shared Ia determinant.
    Schwartz RH; Fathman CG; Sachs DH
    J Immunol; 1976 Apr; 116(4):929-35. PubMed ID: 56405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of cytotoxic T lymphocytes in HLA-A, -B and -C-identical responder-stimulator pairs. I. Variations in generation of anti-class-II CTL in primary mixed lymphocyte cultures.
    Breuning MH; Breur BS; Engelsma MY; Iványi P
    Tissue Antigens; 1984 Aug; 24(2):81-9. PubMed ID: 6238446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in conformation with loss of alloantigenic determinants of a histocompatibility antigen (HLA-B7) induced by monoclonal antibodies.
    Parham P
    J Immunol; 1984 Jun; 132(6):2975-83. PubMed ID: 6202768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-B POT: a new HLA-antigen within the B7-cross reactive group.
    Reekers P; van der Beucken M; Andrien M; Beelen J; Mueller-Eckhardt G; Schreuder GM
    Tissue Antigens; 1986 Sep; 28(3):182-9. PubMed ID: 2431514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can anti HLA-A and -B antibodies inhibit the MLC test?
    Jonker M; van Rood JJ
    Tissue Antigens; 1978 Mar; 11(3):251-64. PubMed ID: 77568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of class I-specific helper-inducer T-cell clone.
    Nikaein A; Boyer B; McQueen K; Ryan DH
    Hum Immunol; 1987 Jul; 19(3):205-14. PubMed ID: 2957346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Public antigenic determinant on a family of HLA-B molecules.
    Schwartz BD; Luehrman LK; Rodey GE
    J Clin Invest; 1979 Oct; 64(4):938-47. PubMed ID: 90060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human major histocompatibility complex class I antigens: residues 61-83 of the HLA-B7 heavy chain specify an alloreactive site.
    Walker LE; Ketler TA; Houghten RA; Schulz G; Chersi A; Reisfeld RA
    Proc Natl Acad Sci U S A; 1985 Jan; 82(2):539-42. PubMed ID: 3881768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A "spontaneous" cold-reactive IgM antibody with anti HLA-B8 specificity in a patient with multiple sclerosis.
    Lenhard V; Diehm H; Römer W; Rauterberg EW; Kownatzki E; Roelcke D
    Immunobiology; 1982 Feb; 160(5):382-91. PubMed ID: 6175560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of HLA Types with Non-Specific Binding of Negative Control Beads in Luminex Panel Reactive Antibody (PRA) Screening Assay.
    Lee N; Park HS; In JW; Roh EY; Shin S; Park KU; Song EY
    Clin Lab; 2017 Jan; 63(1):169-174. PubMed ID: 28164503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A F(ab')2 fragment blocking study of the HLA-B14 antigen.
    Darke C
    Tissue Antigens; 1985 Apr; 25(4):177-86. PubMed ID: 2409633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of HLA antibody cytotoxicity by intravenous immunoglobulin G F(ab')2 dimers, monomers, and monovalent F(ab).
    Mahoney RJ; Breggia AE
    Hum Immunol; 1999 Jun; 60(6):492-9. PubMed ID: 10408798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum HLA typing.
    Tait BD; Finlay RI; Simons MJ
    Tissue Antigens; 1981 Feb; 17(2):129-35. PubMed ID: 7233413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fine specificity of human HLA-B7-specific cytotoxic T-lymphocyte clones. I. Identification of HLA-B7 subtypes and histotopes of the HLA-B7 cross-reacting group.
    van Seventer GA; Huis B; Melief CJ; Iványi P
    Hum Immunol; 1986 Aug; 16(4):375-89. PubMed ID: 2428783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA antigens of platelets. IV. Influence of "private" HLA--B locus specificities on the expression of Bw4 and Bw6 on human platelets.
    Szatkowski NS; Aster RH
    Tissue Antigens; 1980 Apr; 15(4):361-8. PubMed ID: 7466777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sperm immunity in infertile couples: antibody titers are higher against the husbands' sperm than to sperm from controls.
    Mathur S; Williamson HO; Genco PV; Koopmann WR; Rust PF; Fudenberg HH
    Am J Reprod Immunol (1980); 1983; 3(1):18-22. PubMed ID: 6190414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity of mouse cytotoxic T lymphocytes stimulated with either HLA-A and -B or HLA-DR antigens reconstituted into phospholipid vesicles.
    Engelhard VH; Kaufman JF; Strominger JL; Burakoff SJ
    J Exp Med; 1980 Aug; 152(2 Pt 2):54s-64s. PubMed ID: 6157770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.